Fibrosis is characterized by a proliferation of fibroblasts and excessive extracellular matrix following chronic inflammation, and this replacement of organ tissue with fibrotic tissue causes a loss of function. Inflammatory bowel disease (IBD) is a chronic inflammation of the gastrointestinal tract, and intestinal fibrosis is common in IBD patients, resulting in several complications that require surgery, such as a stricture or penetration. This review describes the pathogenesis and various factors involved in intestinal fibrosis in IBD, including cytokines, growth factors, epithelial-mesenchymal and endothelial-mesenchymal transitions, and gut microbiota. Furthermore, histopathologic findings and scoring systems used for stenosis in IBD are discussed, and differences in the fibrosis patterns of ulcerative colitis and Crohn’s disease are compared. Biomarkers and therapeutic agents targeting intestinal fibrosis are briefly mentioned at the end.
Citations
Citations to this article as recorded by
Leveraging Organ‐on‐Chip Models to Investigate Host–Microbiota Dynamics and Targeted Therapies for Inflammatory Bowel Disease Tim Kaden, Raquel Alonso‐Román, Johannes Stallhofer, Mark S. Gresnigt, Bernhard Hube, Alexander S. Mosig Advanced Healthcare Materials.2025;[Epub] CrossRef
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn’s Disease Xue Yang, Yan Pan, Cai-Ping Gao, Hang Li, Ying-Hui Zhang, Chun-Li Huang, Lu Cao, Shi-Yu Xiao, Zhou Zhou Journal of Inflammation Research.2025; Volume 18: 1413. CrossRef
Fibrosierende Erkrankungen im Gastrointestinaltrakt Elke Roeb Die Innere Medizin.2025;[Epub] CrossRef
Roles of fibroblasts in the pathogenesis of inflammatory bowel diseases and IBD-associated fibrosis Takayoshi Ito, Hisako Kayama International Immunology.2025;[Epub] CrossRef
Disease Clearance in Ulcerative Colitis: A Narrative Review Silvio Danese, Laurent Peyrin‐Biroulet, Vipul Jairath, Ferdinando D'Amico, Shashi Adsul, Christian Agboton, Fernando Magro United European Gastroenterology Journal.2025;[Epub] CrossRef
Gut Microbiota as a Mediator Between Intestinal Fibrosis and Creeping Fat in Crohn's Disease Caiguang Liu, Rongchang Li, Jing Nie, Jinshen He, Zihao Lin, Xiaomin Wu, Jinyu Tan, Zishan Liu, Longyuan Zhou, Xiaozhi Li, Zhirong Zeng, Minhu Chen, Shixian Hu, Yijun Zhu, Ren Mao United European Gastroenterology Journal.2025;[Epub] CrossRef
Per- and polyfluoroalkyl substances (PFAS): immunotoxicity at the primary sites of exposure Emma Arnesdotter, Charlotte B. A. Stoffels, Wiebke Alker, Arno C. Gutleb, Tommaso Serchi Critical Reviews in Toxicology.2025; 55(4): 484. CrossRef
Disease-Specific Novel Role of Growth Differentiation Factor 15 in Organ Fibrosis Harshal Sawant, Alip Borthakur International Journal of Molecular Sciences.2025; 26(12): 5713. CrossRef
Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis M. Seco-Cervera, D. Ortiz-Masiá, D.C. Macias-Ceja, S. Coll, L. Gisbert-Ferrándiz, J. Cosín-Roger, C. Bauset, M. Ortega, B. Heras-Morán, F. Navarro-Vicente, M. Millán, J.V. Esplugues, S. Calatayud, M.D. Barrachina Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(2): 166966. CrossRef
Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease Ilaria Laudadio, Claudia Carissimi, Noemi Scafa, Alex Bastianelli, Valerio Fulci, Alessandra Renzini, Giusy Russo, Salvatore Oliva, Roberta Vitali, Francesca Palone, Salvatore Cucchiara, Laura Stronati Inflammation Research.2024; 73(8): 1359. CrossRef
Food additives impair gut microbiota from healthy individuals and IBD patients in a colonic in vitro fermentation model Irma Gonza, Elizabeth Goya-Jorge, Caroline Douny, Samiha Boutaleb, Bernard Taminiau, Georges Daube, Marie–Louise Scippo, Edouard Louis, Véronique Delcenserie Food Research International.2024; 182: 114157. CrossRef
Epigenetic Regulation of EMP/EMT-Dependent Fibrosis Margherita Sisto, Sabrina Lisi International Journal of Molecular Sciences.2024; 25(5): 2775. CrossRef
Mechanisms and therapeutic research progress in intestinal fibrosis Yanjiang Liu, Tao Zhang, Kejian Pan, He Wei Frontiers in Medicine.2024;[Epub] CrossRef
Disease clearance in ulcerative colitis: A new therapeutic target for the future Syed Adeel Hassan, Neeraj Kapur, Fahad Sheikh, Anam Fahad, Somia Jamal World Journal of Gastroenterology.2024; 30(13): 1801. CrossRef
Urinary Hydroxyproline as an Inflammation-Independent Biomarker of Inflammatory Bowel Disease Muriel Huss, Tanja Elger, Johanna Loibl, Arne Kandulski, Benedicta Binder, Petra Stoeckert, Patricia Mester, Martina Müller, Christa Buechler, Hauke Christian Tews Gastroenterology Insights.2024; 15(2): 486. CrossRef
Inflammatory Bowel Disease: Immune Function, Tissue Fibrosis and Current Therapies Jesús Cosín-Roger International Journal of Molecular Sciences.2024; 25(12): 6416. CrossRef
The Diagnosis of Intestinal Fibrosis in Crohn’s Disease—Present and Future Sara Jarmakiewicz-Czaja, Jolanta Gruszecka, Rafał Filip International Journal of Molecular Sciences.2024; 25(13): 6935. CrossRef
Role of gut microbiota in Crohn’s disease pathogenesis: Insights from fecal microbiota transplantation in mouse model Qiang Wu, Lian-Wen Yuan, Li-Chao Yang, Ya-Wei Zhang, Heng-Chang Yao, Liang-Xin Peng, Bao-Jia Yao, Zhi-Xian Jiang World Journal of Gastroenterology.2024; 30(31): 3689. CrossRef
Ultrasound of the bowel with a focus on IBD: the new best practice Christina Merrill, Stephanie R. Wilson Abdominal Radiology.2024; 50(2): 555. CrossRef
Unveiling the anti-inflammatory potential of 11β,13-dihydrolactucin for application in inflammatory bowel disease management Melanie S. Matos, María Ángeles Ávila-Gálvez, Antonio González-Sarrías, Nuno-Valério Silva, Carolina Lage Crespo, António Jacinto, Ana Teresa Serra, Ana A. Matias, Cláudia Nunes dos Santos Food & Function.2024; 15(18): 9254. CrossRef
Gut microbiota and mesenteric adipose tissue interactions in shaping phenotypes and treatment strategies for Crohn’s disease Anis Hasnaoui, Racem Trigui, Mario Giuffrida World Journal of Gastroenterology.2024; 30(46): 4969. CrossRef
Pathways Affected by Falcarinol-Type Polyacetylenes and Implications for Their Anti-Inflammatory Function and Potential in Cancer Chemoprevention Ruyuf Alfurayhi, Lei Huang, Kirsten Brandt Foods.2023; 12(6): 1192. CrossRef
Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans Romy M. Heilmann, Georg Csukovich, Iwan A. Burgener, Franziska Dengler Frontiers in Veterinary Science.2023;[Epub] CrossRef
Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition Dulce C. Macias-Ceja, M. Teresa Mendoza-Ballesteros, María Ortega-Albiach, M. Dolores Barrachina, Dolores Ortiz-Masià Frontiers in Cell and Developmental Biology.2023;[Epub] CrossRef